Search by Drug Name or NDC
NDC 67877-0753-60 Dronabinol 2.5 mg/1 Details
Dronabinol 2.5 mg/1
Dronabinol is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is DRONABINOL.
MedlinePlus Drug Summary
Dronabinol is used to treat nausea and vomiting caused by chemotherapy in people who have already taken other medications to treat this type of nausea and vomiting without good results. Dronabinol is also used to treat loss of appetite and weight loss in people who have acquired immunodeficiency syndrome (AIDS). Dronabinol is in a class of medications called cannabinoids. It works by affecting the area of the brain that controls nausea, vomiting, and appetite.
Related Packages: 67877-0753-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dronabinol
Product Information
| NDC | 67877-0753 |
|---|---|
| Product ID | 67877-753_ef3763f7-d386-4bbb-bda6-264e3a99593b |
| Associated GPIs | 50300030000110 |
| GCN Sequence Number | 004694 |
| GCN Sequence Number Description | dronabinol CAPSULE 2.5 MG ORAL |
| HIC3 | H6O |
| HIC3 Description | ANTIEMETIC, CANNABINOID-TYPE |
| GCN | 27990 |
| HICL Sequence Number | 001955 |
| HICL Sequence Number Description | DRONABINOL |
| Brand/Generic | Generic |
| Proprietary Name | Dronabinol |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dronabinol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | DRONABINOL |
| Labeler Name | Ascend Laboratories, LLC |
| Pharmaceutical Class | Cannabinoid [EPC], Cannabinoids [CS] |
| DEA Schedule | CIII |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA018651 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 67877-0753-60 (67877075360)
| NDC Package Code | 67877-753-60 |
|---|---|
| Billing NDC | 67877075360 |
| Package | 60 CAPSULE in 1 BOTTLE (67877-753-60) |
| Marketing Start Date | 2021-03-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.51597 |
| Pricing Unit | EA |
| Effective Date | 2023-12-20 |
| NDC Description | DRONABINOL 2.5 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis